Home
News
Create
Screeners
Insights
Gujarat Kidney and Super Speciality
141.
25
-2.02
(-1.41%)
Market Cap
₹1,113.66 Cr
PE Ratio
84.59
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-1.41%
1M
+27.94%
6M
+35.12%
1Y
+35.12%
5Y
+35.12%
View Company Insights
Latest news about Gujarat Kidney and Super Speciality
Board meets May 28 to consider Q4, FY26 results
2 days ago
Gujarat Kidney And Superspeciality Limited will hold a board meeting on May 28, 2026, to consider audited financial results for the quarter and year ended March 31, 2026. The agenda also includes a variation in IPO objects, conducting a postal ballot, and appointing a CEO. The trading window for designated persons is closed from April 1, 2026, until 48 hours after the results are announced.
Gujarat Kidney and Super Speciality to Deploy 100 AI-Powered Haemodialysis Machines Across Gujarat Network
10 days ago
Gujarat Kidney and Super Speciality Limited Postal Ballot Results: All Resolutions Approved
Apr 25, 2026
Gujarat Kidney Pays Rs 20,000 Fines to BSE and NSE for Board Meeting Delay
Apr 22, 2026
Gujarat Kidney and Super Speciality Limited Submits SEBI Compliance Certificate for Q4FY26
Apr 07, 2026
More news about Gujarat Kidney and Super Speciality
26
Mar 26
Gujarat Kidney Completes Postal Ballot Notice Dispatch for IPO Fund Reallocation
Gujarat Kidney and Super Speciality Limited has completed the dispatch of its postal ballot notice to shareholders, announcing through newspaper publications on March 26, 2026. The company seeks approval for reallocating ₹3,692.50 lakhs of unutilized IPO funds from women's hospital and robotics equipment to developing a multi-specialty hospital in Bharuch and dialysis services collaboration. The e-voting process runs from March 27 to April 25, 2026, with results expected within two working days.
23
Mar 26
Gujarat Kidney and Super Speciality Limited Acquires Parekhs Hospital for ₹77 Crore
Gujarat Kidney and Super Speciality Limited completed acquisition of Parekhs Hospital Private Limited as wholly owned subsidiary on March 22, 2026, for ₹77 crore cash consideration. The target company, incorporated in 2006, operates in medical and healthcare services with revenues of ₹25.67 crore in FY25. The strategic acquisition aims to strengthen presence in healthcare sector and diversify business portfolio.
21
Mar 26
Gujarat Kidney Pays ₹6.61 Lakh Penalty to NSE and BSE for Regulatory Non-Compliance
Gujarat Kidney and Super Speciality Limited has completed payment of regulatory penalties totaling ₹6,60,800 to NSE and BSE for failing to submit quarterly financial results within prescribed timelines. The company paid ₹3,30,400 to each exchange via RTGS on March 20, 2026, following penalty notices received on March 17, 2026, and has formally communicated the settlement to both exchanges.
19
Mar 26
Gujarat Kidney Appoints Auditors and Approves Postal Ballot with Q2 FY25 Results
Gujarat Kidney And Superspeciality Limited conducted a board meeting on March 19, 2026, appointing Mr. Dharmendra Bhaliya as Secretarial Auditor and Mr. Siddharth Atulbhai Shah as Internal Auditor for FY 2025-26. The board also approved postal ballot notice and ratified Q2 FY25 financial results, which showed consolidated revenue growth of 37.40% to ₹1,292.88 lacs despite a decline in net profit.
13
Mar 26
Gujarat Kidney And Super Speciality Limited Reports Mixed Q2FY26 Results with Revenue Decline
Gujarat Kidney And Super Speciality Limited reported Q2FY26 standalone revenue of ₹964.26 lacs, up 2.47% YoY, but net profit declined 22.17% to ₹230.12 lacs due to rising expenses. Half-year performance showed stronger growth with revenue increasing 12.97% to ₹2,109.25 lacs and net profit rising 10.12% to ₹620.10 lacs. Consolidated results demonstrated significant revenue growth of 37.40% to ₹1,292.88 lacs, reflecting successful expansion through subsidiaries, though profitability remained under pressure with EPS declining across both standalone and consolidated operations.
Gujarat Kidney and Super Speciality
141.
25
-
2.
02
(-
1.
41
%)
1 Year Returns:
+35.12%
Industry Peers
Apollo Hospitals
8,404.00
(+
0.
50
%)
Max Healthcare Institute
1,000.85
(-
2.
19
%)
Fortis Healthcare
970.35
(+
1.
04
%)
Narayana Hrudayalaya
1,940.00
(+
4.
55
%)
Aster DM Healthcare
746.90
(-
1.
28
%)
Global Health
1,249.30
(+
0.
90
%)
Krishna Institute of Medical Sciences
756.80
(-
0.
96
%)
Dr. Agarwal's Health Care
479.70
(+
0.
07
%)
Rainbow Childrens Medicare
1,350.00
(-
0.
37
%)
Park Medi World
279.09
(+
7.
68
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar